We are live on
!
Find out more
Pediatrix Medical
Fund managers haven’t disclosed any holdings of MD yet.
MD Hedge Fund Activity: Q1 2026 in Review
296 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2026, worth a combined $1.78B — up 0.27% from $1.77B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new MD positions and 36 closed out — a net gain of 4 holders — while 106 added to existing stakes and 99 trimmed.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $42.7M. The largest seller was Boston Partners, exiting entirely with an estimated $17.2M sold.
- 296 institutional investors held Pediatrix Medical (MD) as of Q1 2026, down from 299 in Q4 2025.
- Funds reported $1.78B of Pediatrix Medical stock for Q1 2026, up 0.27% quarter-over-quarter.
- 40 funds opened new Pediatrix Medical positions in Q1 2026 and 36 closed out, a net change of +4 holders.
- The largest Pediatrix Medical buyer in Q1 2026 was Wasatch Advisors, an estimated $42.7M added.
- The largest Pediatrix Medical seller in Q1 2026 was Boston Partners, an estimated $17.2M sold.
Based on aggregated 13F filings for Q1 2026.